IL72990A - 5-nitro(or amino)-4(3h)-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

5-nitro(or amino)-4(3h)-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL72990A
IL72990A IL72990A IL7299084A IL72990A IL 72990 A IL72990 A IL 72990A IL 72990 A IL72990 A IL 72990A IL 7299084 A IL7299084 A IL 7299084A IL 72990 A IL72990 A IL 72990A
Authority
IL
Israel
Prior art keywords
nitro
amino
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL72990A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL72990A publication Critical patent/IL72990A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL72990A 1983-09-21 1984-09-18 5-nitro(or amino)-4(3h)-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them IL72990A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,426 US4772704A (en) 1983-09-21 1983-09-21 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity

Publications (1)

Publication Number Publication Date
IL72990A true IL72990A (en) 1990-07-12

Family

ID=24129972

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72990A IL72990A (en) 1983-09-21 1984-09-18 5-nitro(or amino)-4(3h)-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them

Country Status (36)

Country Link
US (1) US4772704A (xx)
JP (1) JPH0643310B2 (xx)
KR (1) KR900001198B1 (xx)
AR (2) AR242385A1 (xx)
AT (1) AT387965B (xx)
AU (1) AU583479B2 (xx)
BE (1) BE900652A (xx)
CA (1) CA1260463A (xx)
CH (1) CH665840A5 (xx)
CS (1) CS249147B2 (xx)
CY (1) CY1561A (xx)
DD (1) DD226881A5 (xx)
DE (1) DE3434578A1 (xx)
DK (1) DK162987C (xx)
ES (4) ES8607253A1 (xx)
FI (1) FI83868C (xx)
FR (1) FR2552082B1 (xx)
GB (1) GB2146994B (xx)
GR (1) GR80439B (xx)
HK (1) HK73790A (xx)
HU (1) HU193227B (xx)
IE (1) IE58083B1 (xx)
IL (1) IL72990A (xx)
IT (1) IT1176739B (xx)
LU (1) LU85550A1 (xx)
NL (1) NL8402898A (xx)
NO (1) NO161561C (xx)
NZ (1) NZ209572A (xx)
OA (1) OA07820A (xx)
PT (1) PT79256B (xx)
SE (1) SE463209B (xx)
SG (1) SG60890G (xx)
YU (1) YU45205B (xx)
ZA (1) ZA847345B (xx)
ZM (1) ZM4984A1 (xx)
ZW (1) ZW16084A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質tan―1057,その製造法および用途
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (xx) * 1978-02-13 1983-03-05 Smith Kline French Lab
ES477520A1 (es) * 1978-02-25 1979-06-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevas penicilinas.
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives

Also Published As

Publication number Publication date
CA1260463A (en) 1989-09-26
JPS6087271A (ja) 1985-05-16
NO843726L (no) 1985-03-22
AR242789A1 (es) 1993-05-31
US4772704A (en) 1988-09-20
KR850002259A (ko) 1985-05-10
IE58083B1 (en) 1993-06-30
DD226881A5 (de) 1985-09-04
SE8404729D0 (sv) 1984-09-20
GR80439B (en) 1985-01-22
PT79256A (en) 1984-10-01
ZA847345B (en) 1985-06-26
HU193227B (en) 1987-08-28
NL8402898A (nl) 1985-04-16
CH665840A5 (de) 1988-06-15
AU3335184A (en) 1985-03-28
ES551500A0 (es) 1987-03-16
FI843643A0 (fi) 1984-09-18
FI843643L (fi) 1985-03-22
NO161561B (no) 1989-05-22
NZ209572A (en) 1988-05-30
AT387965B (de) 1989-04-10
GB8423863D0 (en) 1984-10-24
DK450484A (da) 1985-03-22
ES8607253A1 (es) 1986-05-16
HK73790A (en) 1990-09-28
IE842406L (en) 1985-03-21
AU583479B2 (en) 1989-05-04
PT79256B (en) 1986-11-20
YU161384A (en) 1987-12-31
ES536054A0 (es) 1986-05-16
ES8702897A1 (es) 1987-01-16
IT8422744A0 (it) 1984-09-20
FI83868C (fi) 1991-09-10
DK450484D0 (da) 1984-09-20
ES551501A0 (es) 1987-01-16
DE3434578A1 (de) 1985-04-11
ZW16084A1 (en) 1985-01-16
DK162987C (da) 1992-06-01
CY1561A (en) 1991-03-22
CS249147B2 (en) 1987-03-12
DK162987B (da) 1992-01-06
AR242385A1 (es) 1993-03-31
OA07820A (fr) 1986-11-20
GB2146994A (en) 1985-05-01
ZM4984A1 (en) 1985-05-21
SE463209B (sv) 1990-10-22
KR900001198B1 (ko) 1990-02-28
LU85550A1 (fr) 1985-06-04
SG60890G (en) 1990-09-07
SE8404729L (sv) 1985-03-22
YU45205B (en) 1992-05-28
BE900652A (fr) 1985-03-21
ATA300984A (de) 1988-09-15
GB2146994B (en) 1987-09-03
HUT35259A (en) 1985-06-28
JPH0643310B2 (ja) 1994-06-08
FR2552082B1 (fr) 1987-02-20
IT8422744A1 (it) 1986-03-20
FI83868B (fi) 1991-05-31
ES8704465A1 (es) 1987-04-01
IT1176739B (it) 1987-08-18
ES544213A0 (es) 1987-04-01
ES8704155A1 (es) 1987-03-16
NO161561C (no) 1989-08-30
FR2552082A1 (fr) 1985-03-22

Similar Documents

Publication Publication Date Title
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL64256A0 (en) 2,4-diamino-(5-substituted)pyrimidines,their preparation and pharmaceutical compositions containing them
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL65803A (en) Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them
PH22022A (en) Pyrimidine derivatives, pharmaceutical composition containing same and use thereof
IL64665A (en) 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL64777A0 (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
IL70756A0 (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL66408A0 (en) Amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL73332A0 (en) Triazine derivatives,their preparation and pharmaceutical compositions containing them
IL76176A0 (en) Ethylenediamine monoamide derivatives,their manufacture and pharmaceutical compositions containing them
IL72151A0 (en) Tetrahydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them
IL70755A (en) 3-amino-4-cyano-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL65327A0 (en) Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them
IL66424A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL73222A0 (en) Benzenesulfonyl-lactam derivatives,their preparation and pharmaceutical compositions containing them
IL72562A (en) 6,7-dimethoxy-4-piperidino-quinazoline derivatives and pharmaceutical compositions containing them
IL66238A0 (en) Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them
IL71711A0 (en) Pyrimidone derivatives,their manufacture and pharmaceutical compositions containing them
IL65422A (en) 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL89376A0 (en) Substituted pyrimidines,their preparation and pharmaceutical compositions containing them
IL83452A0 (en) Pyrimidine derivatives,their manufacture and pharmaceutical compositions containing them
IL84728A0 (en) Triazine derivatives,their manufacture and pharmaceutical compositions containing them
IL73776A (en) N-phenyl-1h-tetrazole-5-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
IL72990A (en) 5-nitro(or amino)-4(3h)-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void